Bristol-Myers Squibb Company
Antibodies to alpha-synuclein and uses thereof

Abstract:

Disclosed herein are anti-.alpha.-synuclein antibodies which preferentially bind to oligomeric .alpha.-synuclein over monomeric .alpha.-synuclein, therapeutic compositions comprising the antibodies, and methods of using the antibodies to treat synucleinopathies.